Tag Archive | "chemotherapy"

Depressed Head and Neck Cancer Patients Have Lower Survival and Higher Recurrence Risk

Wednesday, December 30, 2015

0 Comments

Source: www.OncologyNurseAdvisor.com Author: Kathy Boltz, PhD   Depression is a significant predictor of 5-year survival and recurrence in patients with head and neck cancer, according to a new study published in Pyschosomatic Medicine (doi: 10.1097/PSY.0000000000000256). These findings represent one of the largest studies to report on the impact of depression on cancer survival. Although depression […]

Continue reading...

Poison’s Rikki Rockett Reveals He Is Battling Oral Cancer

Tuesday, December 15, 2015

0 Comments

Source: www.loudwire.com Author: Chad Childers   Poison drummer Rikki Rockett revealed during an appearance on the Eddie Trunk Live radio show that he’s completed nine rounds of chemotherapy and seven weeks of radiation treatments after being diagnosed with oral cancer this past summer and that he’ll find out in February if the treatments were successful. […]

Continue reading...

SA Developed Melanoma Drug Now Seen Effective in Fighting Lung Cancer

Tuesday, October 6, 2015

0 Comments

Source: www.woai.com Author: News Radio 1200 WOAI Staff   Keytruda, a cancer drug developed largely at San Antonio’s START Center, has already proven to be effective in treating advanced melanoma to the point that it is the major part of former President Jimmy Carter’s treatment.  Now, News Radio 1200 WOAI reports Keytruda has been given […]

Continue reading...

Imaging method has potential to stratify head and neck cancer patients

Saturday, September 19, 2015

0 Comments

Source: www.eurekalert.org Author: press release Manchester researchers have identified a potential new way to predict which patients with head and neck cancer may benefit most from chemotherapy. These patients commonly receive pre-treatment induction chemotherapy, before either surgery or radiotherapy, to reduce the risk of disease spread. However the effectiveness of such treatment is reduced in […]

Continue reading...

AstraZeneca joins the world of immunotherapy against cancer

Thursday, August 13, 2015

0 Comments

Source: www.youthhealthmag.com Author: staff Cancer drug companies have been fighting lately in a completely different and interesting arena: immunotherapy. The competition is indeed heating up that firms such as AstraZeneca are willing to pay millions of dollars for promising treatments. AstraZeneca, through its research company called MedImmune, has just recently announced its decision to purchase […]

Continue reading...

The Cost of Cancer Drugs

Monday, June 22, 2015

0 Comments

Source: www.cbsnew.com Author: Lesley Stahl   The following is a script of “The Cost of Cancer Drugs” which aired on October 5, 2014, and was rebroadcast on June 21, 2015. Lesley Stahl is the correspondent. Richard Bonin, producer. Cancer is so pervasive that it touches virtually every family in this country. More than one out […]

Continue reading...

Keytruda doubles efficacy of only targeted therapy for head and neck cancer

Thursday, June 11, 2015

0 Comments

Source: www.curetoday.com Author: Lauren M. Green The immunotherapy Keytruda (pembrolizumab), in a recent study, proved twice as effective for the treatment of head and neck cancer as Erbitux (cetuximab), the only targeted therapy indicated as a therapy for the disease. The multisite study offers the largest experience to date of how immunotherapy can be deployed […]

Continue reading...

Factors linked with better survival in oral cancer identified

Saturday, May 16, 2015

0 Comments

Source: www.cancertherapyadvisor.com Author: staff Factors associated with improved survival in oral cavity squamous cell cancer (OCSCC) include neck dissection and treatment at academic or research institutions, according to a study published in JAMA Otolaryngology-Head & Neck Surgery. Alexander L. Luryi, from the Yale University School of Medicine in New Haven, Conn., and colleagues analyzed correlations […]

Continue reading...

Second-line afatinib shows promise

Wednesday, May 6, 2015

0 Comments

Source: www.nature.com Author: David Killock Patients with recurrent and/or metastatic head and neck squamous-cell carcinoma and disease progression after first-line platinum-based chemotherapy have a dismal prognosis. There is no standard second-line therapy; however, afatinib, an irreversible inhibitor of HER family kinases, has shown efficacy in this setting. The LUX-Head & Neck 1 phase III trial […]

Continue reading...

Laser Treatment Halts Oral Mucositis in Its Tracks

Monday, May 4, 2015

0 Comments

Source: www.medscape.com Author: Fran Lowry   Spa-like treatment with a cool, low-level laser, similar to that use for wrinkles, vanquishes oral mucositis, one of the most debilitating toxicities of cancer therapy.   “I have been an oncology nurse for over 25 years, and in those 25 years, there has been nothing that helps prevent or […]

Continue reading...